. 2012 Sep;14(9):828–834. doi: 10.1089/dia.2011.0277

Table 1.

Clinical, Anthropometric, and Biochemical Profiles

Variable	Obese (n=273)	Nonobese (n=222)	P	IR (n=117)	Non-IR (n=368)	P
Age (years)	38.4±9.1	40.8±8.3	0.003^a	39.6±8.9	39.2±8.5	0.6
Body mass index (kg/m²)	28.6±2.8	21.5±2.3	0.01^a	27.3±4.2	24±4.1	0.001^a
Waist circumference (cm)	93.7±9.8	81.0±10.5	0.001^a	91.6±10.5	85.0±12.2	0.001^a
Hip circumference (cm)	101.5±7.9	90.2±7.8	0.001^a	99.5±7.8	93.7±9.7	0.001^a
Waist–hip ratio	0.91±0.06	0.89±0.09	0.004^a	0.90±0.1	0.90±0.2	0.5
Skinfold thickness (mm)
Biceps	20.7±8.5	14.5±7.7	0.001^a	21.3±8.1	16.0±5.2	0.001^a
Triceps	28.2±9.6	20.5±7.9	0.001^a	27.5±8.5	22.7±9.2	0.001^a
Subscapular	35.8±7.7	27.1±7.9	0.001^a	35.2±7.9	29.5±8.8	0.001^a
Suprailiac	39.7±7.7	27.8±9.2	0.001^a	41.6±7.2	30.4±10.6	0.001^a
Total	119.7±26.9	90±27.1	0.001^a	120.4±24.3	97.2±21.2	0.001^a
FPG (mmol/L)	5.2±1.3	5.0±0.7	0.2	5.1±1.0	5.0±0.9	0.4
Triglycerides (mmol/L)	9.2±2.4	7.0±2.9	0.001^a	9.1±2.6	7.1±2.9	0.001^a
Total cholesterol (mmol/L)	10.6±2.1	9.9±2.7	0.001^a	11.1±2.2	10±2.3	0.008^a
LDL-C (mmol/L)	6.4±1.9	6.1±2.0	0.1	6.5±1.6	5.6±1.2	0.2
HDL-C (mmol/L)	2.3±0.6	2.3±0.6	0.5	2.3±0.5	2.6±0.8	0.5
VLDL (mmol/L)	1.8±0.6	1.43±0.5	0.04^a	1.8±0.9	1.5±0.8	0.01^a
Serum leptin (μg/L)	28.1 (0.4–98.3)^b	10.8 (0.3–61.2)^b	0.001^a	24±7.2	17.2±6.2	0.002^a
Serum adiponectin (ng/L)	26.8±9.5	34.8±9.2	0.02^a	26.2±8.9	32.1±9.2	0.005^a
Fasting insulin (μU/L)^b	9.9 (0.3–41.2)	6.5 (0.2–52.3)	0.001^a	15.5 (1.2–63.4)	5.7 (0.5–41.6)	0.001^a
HOMA-IR^b	3.2 (0.1–9.7)	1.3 (0–12.1)	0.001^a	3.5 (0.1–11.7)	1.2 (0.1–9.9)	0.003^a

Data are mean±SD values for the indicated number of subjects (n) unless indicated otherwise.

^{^a}

Significant difference.

^{^b}

Median (minimum – maximum).

FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; HOMA, homoeostasis model assessment for insulin resistance; IR, insulin resistance; LDL-C, low-density lipoprotein cholesterol; VLDL, very low-density lipoprotein.